Marine Compounds and Cancer / / edited by Friedemann Honecker, Sergey A. Dyshlovoy

• Pubblicazione: Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2018
• Descrizione fisica: 1 online resource (v, 110 pages)
• Disciplina: 615.945
• Soggetto topico: Cancer - Radiotherapy; Marine toxins
• Persona (resp. second.): HoneckerFriedemann; DyshlovoySergey A.
• Sommario/riassunto: The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development.
• Titolo autorizzato: Marine Compounds and Cancer
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910597915403321
• Lo trovi qui: Univ. Federico II